Market snapshot: Oct 13, 2026, 3:00 AM UTC. Prices may have changed since this snapshot.

GroupPOLYMARKET

Event GroupPOLYMARKETFinance

Abbott Laboratories (ABT) Q3 comparable sales growth?

Name: Abbott Laboratories (ABT) Q3 comparable sales growth?
End: 2026-10-21T13:30:00.000Z

Total Volume

$275.56

Events

Markets

Trade on Polymarket

Abbott Laboratories (ABT) Q3 comparable sales growth?

Vol

$275.56

Events

Markets

Polymarket

Platform StatsQuick Platform Comparison

Polymarket

markets · $275.56

Kalshi

markets · $0.00

Price Spread

0.0%avg

max 0.0%

Arbitrage

of 0 cross-platform

Volume DistributionTotal: $275.56

100%

Polymarket leads

Price ChartMatched Markets Price Graph

5 markets tracked

Historical observations can differ from current quotes. Kalshi points are hourly trade averages.

Abbott Laboratories (ABT) Q3 comparable sales growth 6% to 8%?

No data available

Single-Platform Markets(5)

Market	Platform	Price
Abbott Laboratories (ABT) Q3 comparable sales growth 6% to 8%?	Poly	26%
Abbott Laboratories (ABT) Q3 comparable sales growth <4%?	Poly	21%
Abbott Laboratories (ABT) Q3 comparable sales growth 10%+?	Poly	16%
Abbott Laboratories (ABT) Q3 comparable sales growth 4% to 6%?	Poly	15%
Abbott Laboratories (ABT) Q3 comparable sales growth 8% to 10%?	Poly	14%

AI Analysis

Trader mode: Actionable analysis for identifying opportunities and edge

26%

Top Probability

$275.56

Volume

Markets

Platforms

About This Event

This market will resolve according to Abbott Laboratories' comparable sales growth (year-over-year) for the upcoming third fiscal quarter, as reported in its official company earnings materials. The specified metric will be considered as reported in the company's official earnings materials. Subsequent revisions will not be considered. If the specified company's official earnings materials for the specified quarter are released, and the specified metric is not included, this market will resolv

AI-generated analysis based on market data. Not financial advice.

Custom AI Analysis Prompt

Tap to expand

Open in:ChatGPT Claude Gemini Grok DeepSeek

**Role:** Expert Prediction Market Analyst & Trader
**Objective:** Analyze the provided betting market data to deliver actionable insights, identify mispricings, and perform scenario analysis.
**Current Date:** Tuesday, October 13, 2026
**Context:** Prediction markets (Polymarket/Kalshi) are binary option markets where price (1-99) equals implied probability (1%-99%).

---

## 1. Event Snapshot
**Event:** Abbott Laboratories (ABT) Q3 comparable sales growth?
**Category:** Finance | **Status:** active
**Resolution Date:** Oct 21, 2026 (9 days left)
**Time Pressure:** Medium

**Description:** This market will resolve according to Abbott Laboratories' comparable sales growth (year-over-year) for the upcoming third fiscal quarter, as reported in its official company earnings materials.

The specified metric will be considered as reported in the company's official earnings materials. Subsequent revisions will not be considered.

If the specified company's official earnings materials for the specified quarter are released, and the specified metric is not included, this market will resolv

**Resolution Criteria (Sample):**
"This market will resolve according to Abbott Laboratories' comparable sales growth (year-over-year) for the upcoming third fiscal quarter, as reported in its official company earnings materials.

The specified metric will be considered as reported in the company's official earnings materials. Subseq"

## 2. Market liquidity & Volume
* **Total Volume:** $276
* **Total Liquidity:** $993
* **Activity Level:** Low Activity (Vol/Liq Ratio: 0.28)

## 3. Market Data (Prices & Odds)
### 1. Abbott Laboratories (ABT) Q3 comparable sales growth <4%?
- **Polymarket** (End: Oct 21, 2026): Vol $0
  DATA: [Yes: 21.0% (0.0%)] | [No: 79.0% (0.0%)]

### 2. Abbott Laboratories (ABT) Q3 comparable sales growth 4% to 6%?
- **Polymarket** (End: Oct 21, 2026): Vol $20
  DATA: [Yes: 15.0% (0.0%)] | [No: 85.0% (0.0%)]

### 3. Abbott Laboratories (ABT) Q3 comparable sales growth 6% to 8%?
- **Polymarket** (End: Oct 21, 2026): Vol $43
  DATA: [Yes: 25.5% (0.0%)] | [No: 74.5% (0.0%)]

### 4. Abbott Laboratories (ABT) Q3 comparable sales growth 8% to 10%?
- **Polymarket** (End: Oct 21, 2026): Vol $0
  DATA: [Yes: 14.5% (0.0%)] | [No: 85.5% (0.0%)]

### 5. Abbott Laboratories (ABT) Q3 comparable sales growth 10%+?
- **Polymarket** (End: Oct 21, 2026): Vol $213
  DATA: [Yes: 16.0% (0.0%)] | [No: 84.0% (0.0%)]

---

## Analysis Instructions
Please provide a structured analysis using the following template:

### 1. Executive Summary
*   **Verdict:** [Most Likely Outcome]
*   **Confidence:** [0-100]%
*   **Timeframe:** [Immediate / Short-term / Long-term]
*   **Actionable Trade:** [Buy YES / Buy NO / Stay Away] (Include entry price target if applicable)
*   **Rationale:** 2-sentence summary of the core thesis.

### 2. Scenario Analysis
*   **Bull Case (Why YES goes up):** List specific catalysts or data points.
*   **Bear Case (Why YES goes down):** List specifics.
*   **Invalidation Point:** What happens to prove your thesis wrong?

### 3. Market Mechanics & Risks
*   **Liquidity/Volume Analysis:** Is the market efficient? Is it easy to exit?
*   **Cross-Platform Arbitrage:** (If applicable) Is the spread tradeable after fees?
*   **Time Decay:** How does time passing affect this position?

### 4. Signal Scores (0-100)
*   **Momentum:** [Score] (Price trend & velocity)
*   **Conviction:** [Score] (Volume backing the move)
*   **Information Edge:** [Score] (Likelihood of non-public info affecting price)
*   **Risk/Reward:** [Score] (Potential upside vs downside)

**Constraints:**
- Be direct and objective.
- Use bullet points for readability.
- If data is conflicting or insufficient, explicitly state "Low Confidence".

Tap text to select all

AI-written background. References identify the evidence used; Wikipedia links under Learn More are additional reading. Prices and provider rules are dated snapshots. This is not financial advice.

POLYMARKETFinance